Document: Guidance on the anonymisation of protected personal data and assessment of commercially confidential information during the preparation of RMPs (main body and annexes 4 and 6)-2025/4/11

Document: Floseal haemostatic matrix (Floseal VH S/D) - Procedural steps and scientific information after initial consultation (archive)-2025/5/26

Document: Infosheet: EMA review of real-world data studies from September 2021 to February 2025-2025/6/30

Document: Overview of comments received on the draft qualification opinion for Simcyp Simulator-2025/8/1

Document: EVVet3 EVWeb Production - Release notes-2025/9/19

国家药监局综合司公开征求《药品质量抽查检验管理办法（征求意见稿）》意见-2025/10/28

Document: Agenda - HMA/EMA Annual Data Forum 2025-2025/11/26

Formal Dispute Resolution and Administrative Hearings of Final Administrative Orders Under Section 505G of the Federal Food, Drug, and Cosmetic Act-2025/12/22

Document: Applications for new human medicines under evaluation: February 2026-2026/2/5

Page: Availability of medicines before and during crises-2026/3/13